Basis: FMP quote market capitalization / book value attributable to common shareholders (matching reported total stockholders equity minus preferred stock). Source: stored company filings and market data; unavailable inputs remain N/A.
The P/B ratio is 2.20 as of 2026-10-06T20:38:17.522Z.
Calculation as of: 2026-10-06T20:38:17.522Z.
Quote observation: 2026-10-06T20:00:00.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 970d877bc7db717cbed859036c212f4e9de57f4ce891843b12d0c27006da4837
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
PB RATIO
2.20
SECTOR MEDIAN · HEALTHCARE
2.39
median of 760 covered companies
CURRENT VS SECTOR MEDIAN
-7.95%
vs the sector median at left
Seaport Therapeutics, Inc. Common Stock
Market Cap
$929.83M
PB Ratio
2.20
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$887.99M
PB Ratio
3.94
TTM Avg
10.91
3Y Avg
9.69
5Y Avg
6.24
| NAME | MARKET CAP | PB RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Seaport Therapeutics, Inc. Common Stock (SPTX) | $929.83M | 2.20 | N/A | N/A | N/A |
| Kura Oncology, Inc. (KURA)vs › | $934.79M | 19.30 | 7.49 | 4.20 | 3.31 |
| CeriBell, Inc. (CBLL)vs › | $923.53M | 7.20 | 4.82 | 4.14 | 4.14 |
| MoonLake Immunotherapeutics (MLTX)vs › | $921.06M | 2.15 | 3.57 | 5.41 | 7.83 |
| HealthStream, Inc. (HSTM)vs › | $914.73M | 2.57 | 2.08 | 2.35 | 2.28 |
| Savara Inc. (SVRA)vs › | $952.91M | 6.63 | 9.42 | 6.64 | 4.98 |
| Aktis Oncology, Inc. (AKTS)vs › | $953.81M | 1.97 | 2.48 | 2.48 | 2.48 |
| Corvus Pharmaceuticals, Inc. (CRVS)vs › | $887.99M | 3.94 | 10.91 | 9.69 | 6.24 |
| Bioventus Inc. (BVS)vs › | $887.50M | 3.89 | 3.59 | 3.23 | 2.55 |
| Pacira BioSciences, Inc. (PCRX)vs › | $973.93M | 1.45 | 1.46 | 1.48 | 2.18 |
P/B Ratio
2.20
Market Price / Book Value per Share
PB Ratio = Market Cap / (Total Shareholders' Equity − Preferred Stock)
The price-to-book ratio compares market capitalization to book value attributable to common shareholders (total equity minus preferred stock). Lower values can indicate a cheaper valuation relative to net assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
